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Although dispensable in vitro, HIV Nef enables high-
level viral replication in infected hosts by an as yet
unexplained mechanism. Previously, we proposed
that Nef functionally cooperates with the viral trans-
activator Tat by derepressing the viral promoter via
a Nef-associated kinase complex (NAKC). Here, we
demonstrate that hnRNP-K, a host factor thought to
facilitate crosstalk between kinases and gene ex-
pression, interacts with Nef and, as part of NAKC, nu-
cleates Nef-interacting kinases, including Lck, PKCd,
and PI-3 kinase, leading to Lck and Erk1/2 activation.
This strongly increased HIV transcription, which
depended on Tat and the NF-kB motif in the viral
promoter, but not on NF-kB activation. Depletion of
hnRNP-K in a Jurkat model of HIV latency increased
Erk1/2 activity and greatly augmented HIV reactivat-
ing stimuli. We conclude that hnRNP-K coordinates
membrane signaling with transcriptional derepres-
sion through Erk1/2 and is targeted by HIV to enable
Tat-mediated transcription.
INTRODUCTION
In the infected host, the Nef protein of HIV is required for high-
level viral replication; however, the molecular mechanism is still
unresolved. nef-deleted virus mutants persist in vivo, but their
replication activity is barely detectable in the peripheral blood
(Deacon et al., 1995). Thus, it had been speculated that Nef influ-
ences viral transcription. Early studies, however, revealed that
Nef has no or, rather, a negative influence on the viral promoter
(Hammes et al., 1989; Kim et al., 1989). Therefore, it was
assumed that the combination of various Nef effects increase
the viral load by indirect means.
The well-documented Nef activity on the downregulation of
T cell surface receptors, namely CD4, was thought to prevent
multiple infections of a single cell and, thus, an overload of the
cellular transcription and translation machinery (Lama, 2003).
The same CD4 downregulation effect was found to increase
the infectivity of viral particles by reducing CD4 incorporation
into the viral coat (Lama et al., 1999; Ross et al., 1999). However,
Nef also enhances infectivity in the absence of CD4 (Chowers398 Cell Host & Microbe 4, 398–408, October 16, 2008 ª2008 Elsevieet al., 1995). Besides enhancing infectivity, Nef increases the
release of viral particles from infected cells in vitro. The latter
correlated with the interaction of the Vav protein, but seemingly
not with an increased transcriptional activity of the HIV promoter
(Fackler et al., 1999; Simmons et al., 2005). Finally, Nef was
shown to prolong the survival of the infected cell by activating
antiapoptotic signaling pathways (Geleziunas et al., 2001; Wolf
et al., 2001) and by avoiding CTL-mediated lysis through down-
regulation of MHC class I (Collins et al., 1998).
While the above listed Nef effects may increase the number of
viral particles in vivo, they do not sufficiently explain the absence
of a multilog viral load usually observed in HIV infection, but not in
individuals infected with a nef-negative mutant virus (Learmont
et al., 1999). Thus, the question remains whether Nef-mediated
T cell signaling supports viral transcription in a manner that has
not been elucidated yet.
Previously, we have described a multimeric signaling complex
that associates with the N terminus of Nef and is required for
optimal viral replication (Baur et al., 1997). Therefore, we hypoth-
esized that it was functionally connected to viral transcription.
Notably, the complex contained at least two kinase activities,
namely Lck and a serine kinase, which we recently identified as
a member of the nPKC subfamily (PKCd/q) (Wolf et al., 2008).
Therefore, we termed the complex NAKC for Nef-associated ki-
nase complex. In subsequent studies, we identified the polycomb
protein Eed as a component of NAKC (Witte et al., 2004) (see also
Figure 1A). Eed bound Nef directly and colocalized with Lck at the
plasma membrane. Importantly, it stimulated Tat-dependent
transcription in concert with Nef and supported our initial hypoth-
esis that NAKC was linked to HIV transcription. However, Eed
would not bind Lck or PKC directly, and, thus, its role in NAKC
as well as the connection to both kinases was unclear.
hnRNP-K, or K protein, is a cytoplasmic and nuclear factor that
seems to be involved in many cellular functions, including signal
transduction and gene expression. It contains multiple protein—
as well as RNA- and DNA-binding motifs—and is, therefore,
believed to facilitate the crosstalk between kinases and factors
involved in gene expression (Bomsztyk et al., 2004). In vitro,
hnRNP-K was shown to interact with the tyrosine kinases Lck
and Src, PKCd, and, notably, also with Eed (Adolph et al.,
2007; Bomsztyk et al., 2004; Denisenko and Bomsztyk, 1997;
Ostrowski et al., 2000; Schullery et al., 1999). However, the rele-
vance and function(s) of these associations are not known.
We asked whether hnRNP-K is a component of NAKC and
a bridging factor between Eed and the kinases Lck and PKCd.r Inc.
Cell Host & Microbe
HIV Nef Activates Lck and Erk1/2 via hnRNP-KFigure 1. The Nef-Associated Kinase Complex Is Functionally Coherent and Contains hnRNP-K
(A) Nef-associated kinase complex (NAKC) composition and function as demonstrated previously (Baur et al., 1997). A short a helix in Nef (aa14–21) binds Eed
and coprecipitates Lck and PKCd/q, causing phosphorylation events as indicated. NAKC formation correlated with increased Tat-dependent HIV transcription
(Witte et al., 2004).
(B) CD8-Eed increases Lck activity. Lck (1 mg) was cotransfected with increasing amounts of CD8-Eed or Eed (0.5, 1, 2, 4 mg) into 293T cells, immunoprecipitated,
and subjected to an in vitro kinase assay (IVKA). Lck expression was controlled in lysates of transfected cells.
(C) CD8-Eed stimulates Tat-dependent transcription. The indicated plasmids (2 mg) were cotransfected with an HIV-LTR luciferase reporter (0.5 mg) and subop-
timal amounts of Tat (30 ng) into J.Cam.1 cells, which lack a functional Lck molecule, as described previously (Witte et al., 2004). After 16 hr, luciferase activity was
determined. The p value is based on three experiments. Error bars show means ± SD from three independent experiments. The p value in the graph was
calculated on the basis of the mean values of the indicated bars. p < 0.0024.
(D) Model of NAKC containing hnRNP-K. Red arrows depict the reported interactions in the literature.
(E) Nef recruitsendogenoushnRNP-K.The Nef-mERJurkat line was induced with tamoxifen forvarious time points as indicated before cellswere immunoprecipitated
for Nef-mER and blotted for hnRNP-K association. Subsequently, the NC filter was stripped and blotted for Nef-mER (lower panel). The star indicates the heavy chain.
(F) Nef does not bind hnRNP-K directly. Recombinant proteins (1 mg) derived from bacterial (GST-Eed, Nef) and baculovirus expression systems (hnRNP-K) were
incubated as indicated at 4C/1 hr before Nef was immunoprecipitated and blotted for hnRNP-K.
(G) Nef and hnRNP-K colocalize. Nef-mER Jurkat cells were induced for 30 min, stained for Nef and hnRNP-K, and analyzed by confocal microscopy.
(H) Nef and hnRNP-K colocalize in the cytoplasm, but not the perinuclear region. Same procedure as in (G). White arrows indicate the perinuclear region where
Nef was found without hnRNP-K.Here, we demonstrate that hnRNP-K interacts with Nef in the
context of NAKC and recruits Lck, PKCd, and PI-3 kinase.
Formation of the complex was sufficient to activate Lck and
Erk1/2, which, in T cells, caused a strong Tat-dependent in-
crease of HIV transcription. Our study describes a signaling
module that connects key T cell kinases with transcription and
further unravels the complex but potent mechanism by which
Nef supports HIV transcription.Cell HoRESULTS
One of the hallmarks of the Nef-associated kinase complex
(NAKC) was the increased autophosphorylation of coprecipi-
tated Lck in vitro (Baur et al., 1997) (Figure 1A). Lck, on the
other hand, was crucial for the cooperation of Nef with Tat
and its stimulating effect on HIV transcription (Witte et al.,
2004). Therefore, we decided to determine the mechanism byst & Microbe 4, 398–408, October 16, 2008 ª2008 Elsevier Inc. 399
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HIV Nef Activates Lck and Erk1/2 via hnRNP-Kwhich Nef activates Lck in order to understand its role in HIV
transcription.
First, we wanted to confirm that NAKC was sufficient to acti-
vate Lck, which would suggest that it was a functionally indepen-
dent and coherent signaling complex. To verify this assumption,
we asked whether Eed, which connects the Nef N terminus with
NAKC (Figure 1A), would activate Lck similarly as Nef when
targeted to the plasma membrane by a CD8 tag. We used the
previously described CD8-Eed fusion-protein (Witte et al.,
2004), which was transfected into Jurkat cells. As demonstrated
in Figure 1B, increasing amounts of CD8-Eed increased the ac-
tivity of endogenous Lck, whereas the same amount of nonfused
Eed had no effect.
For further confirmation, we asked whether CD8-Eed would
induce the assumed downstream effect of NAKC, namely an
increase of Tat-dependent HIV transcription. Lck was cotrans-
fected with Eed or CD8-Eed, suboptimal amounts of Tat, and
an HIV-LTR-Luc reporter plasmid into J.CaM.1 cells, similar as
described previously (Witte et al., 2004). As shown in Figure 1C,
CD8-Eed, but not Eed, was able to stimulate HIV transcription
in a Tat-dependent manner, albeit not as efficient as Nef itself.
Together, these results confirmed that membrane-targeted
Eed/NAKC was sufficient to activate Lck-and Tat-dependent HIV
transcription.
In subsequent experiments, however, we were unable to dem-
onstrate an association between Eed and Lck or PKCd/q (data
not shown) and, therefore, assumed that an additional factor
was involved. hnRNP-K seemed a likely candidate because it in-
teracted directly with both kinases and also with Eed (Bomsztyk
et al., 2004). Using recombinant proteins from bacterial and
baculovirus expression systems, we were able to confirm these
reported interactions, including the direct binding of Nef and Eed
(Figures 1F and S1 available online). Based on these results, we
hypothesized a model for NAKC as depicted in Figure 1D, which
suggested a central role for hnRNP-K.
In order to confirm this model and clarify the role of hnRNP-K,
we first wanted to demonstrate the coimmunoprecipitation of en-
dogenous hnRNP-K with Nef. We used our previously described
inducible Jurkat line expressing a Nef-mER fusion-protein (Witte
et al., 2004). At various time points after induction, Nef-mER
was immunoprecipitated and blotted for endogenous hnRNP-K.
Recruitment of hnRNP-K was observed as early as 10 min and
peaked after 20 min (Figure 1E). Notably, using the same cell
line, we observed an identical kinetic for the recruitment of Eed
by Nef (Witte et al., 2004). As predicted by our model (Figure 1D),
Nef did not bind hnRNP-K directly but required Eed seemingly as
a bridging protein. This was demonstrated in pull-down experi-
ments with recombinant proteins, as described above (Figure 1F).
Since hnRNP-K is found in the nucleus as well as in the cytoplasm,
we analyzed the subcellular localization of Nef and hnRNP-K
in Nef-induced Jurkat cells by confocal microscopy. In 60% of
double-positive cells (Nef, hnRNP-K; p < 0.0016), cytoplasmic
colocalization of both proteins was observed in a membrane/
membrane-proximal (Figure 1G), but not perinuclear, area (white
arrows in Figure 1H), where Nef is internalized after initial mem-
brane targeting. In summary, we had established that Nef
recruited hnRNP-K in T cells using Eed as a bridging molecule.
In a next step, we asked whether hnRNP-K was involved in
Nef/NAKC-mediated Lck activation, which would confirm that400 Cell Host & Microbe 4, 398–408, October 16, 2008 ª2008 Elsevit had a functional role in this complex and would give further
insight into the Lck activation mechanism. Lck activation is
a complex process and requires at least CD4/CD8, CD45, Csk,
and Unc119 (Palacios and Weiss, 2004)—proteins that are only
present in T cells. We reasoned that, in non-T cells and thus in
the absence of these factors, Lck would not be activated unless
by a different mechanism, as, for example, in the context of
NAKC. Therefore, we chose 293T epithelial cells for our analysis.
Lck and other NAKC components (Nef, Eed, hnRNP-K, PKCd)
were cotransfected in different combinations before Lck was
immunoprecipitated and analyzed for in vitro kinase activity
and tyrosine autophosphorylation. Cotransfection of Lck with
one other NAKC component had no effect (Figure 2, lanes
2–5). However, the addition of two or more factors induced Lck
activity (lanes 6–15). For example, the coexpression of hnRNP-K
with Lck was ineffective (lane 2), whereas addition of Nef strongly
increased Lck activity (lane 7). This included the typical mobility
shift pattern of Lck caused by serine phosphorylation (Figure 2,
third panel). Therefore, coexpression of Nef and hnRNP-K was
sufficient for Lck activation in 293T cells, and this combination
was used for subsequent experiments in 293T cells.
The contribution of each NAKC factor toward Lck activity was
notalwaysadditiveandsometimes inhibitory (e.g.,Nef/K,Figure2,
lane 7 versus Nef/K/Eed, lane 12). Potentially, this was a conse-
quence of disproportionate expression levels that caused the
squelching of endogenous NAKC factors. Importantly, however,
the strongest Lck activity, characterized by four tyrosine phos-
phorylated bands generated by in vitro Lck autophosphorylation
(56–63 kDa, see arrows) and an Lck mobility shift of more than
50% generated by in vivo serine phosphorylation (63 kDa), was
seen after cotransfection of all NAKC proteins (lane 15). This
implied that all factors were required for optimal Lck activation.
In order to understand the molecular mechanism leading
to Lck activation, we investigated the hnRNP-K-Lck interaction
in greater detail. hnRNP-K contains two tyrosine residues
(Tyr234,236), which are preferentially phosphorylated by Lck (Os-
trowski et al., 2000), and a proline-rich region (aa289–315), which
was shown to interact with and activate Src family kinases
(Adolph et al., 2007; Bomsztyk et al., 2004). This suggested
that hnRNP-K recruited and activated Lck by a PxxP-SH3 inter-
action mechanism depicted in Figure 3A. To test this assump-
tion, we deleted the proline-rich region (KDPxxP; aa289–315)
and first determined the ability of this mutant to bind Lck.
hnRNP-K and KDPxxP were cotransfected along with Lck into
293T cells and, subsequently, immunoprecipitated and blotted
for Lck association. While the association of hnRNP-K with Lck
was weak but reproducible (Figure 3A, lane 2), we could not
coprecipitate KDPxxP with Lck (lane 3). This indicated that the
proline-rich domain was indeed required to recruit Lck. Surpris-
ingly, however, deletion of the proline domain did not abolish
tyrosine phosphorylation of hnRNP-K by Lck. This was revealed
after a similar transfection experiment blotting immunoprecipi-
tated hnRNP-K and KDPxxP with an antiphospho-tyrosine
antibody (Figure 3B). This result suggested that, contrary to
our expectation, the PxxP-SH3 interaction was not a prerequisite
for hnRNP-K tyrosine phosphorylation and did not stimulate or
increase the Lck kinase activity.
Toverify thisconclusion, Lckactivitywasdetermined in thepres-
ence of KDPxxP. After cotransfection with KDPxxP or hnRNP-Kier Inc.
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HIV Nef Activates Lck and Erk1/2 via hnRNP-KFigure 2. Activation of Lck by NAKC Factors
Lck was cotransfected with additional NAKC factors in various numbers and combinations into 293T cells as indicated. After 24 hr, Lck kinase activity was
assessed by in vitro kinase assay (IVKA) (upper panel) and antiphospho-tyrosine western blot (second panel). Four different forms of tyrosine-phosphorylated
Lck (autophosphorylation in vitro) were distinguished as indicated by the arrows. In parallel, lysates of the transfected cells were blotted for Lck expression
and other NAKC factors, revealing an Lck mobility shift pattern (third panel).and Nef, Lck was immunoprecipitated followed by an in vitro
kinase assay and an antiphopho-tyrosine western blot. In agree-
ment with the last experiment, deletion of the proline-rich domain
did not reduce the kinase activity of Lck (Figure 3C, upper panel).
However, the typical mobility shift pattern of Lck, which is unre-
lated to tyrosine and solely caused by serine phosphorylation,
was inhibited (lower panel). The residual shift activity (lanes 6
and 7) was likely due to the presence of endogenous hnRNP-K.
These findings led to several conclusions (see also detailed
model in Figure 7): (1) Lck recruitment by the proline-rich domain
of hnRNP-K was not required to activate the kinase but for its ser-
ine phosphorylation, and (2) there had to be an associated serine
kinase that phosphorylated Lck.
Before identifying the Lck-phosphorylating serine kinase, we
wanted to clarify whether hnRNPK directly activated Lck. The
TCR-mediated signaling pathway that activates Lck is well
defined (Palacios and Weiss, 2004). Thus, an alternative mecha-
nism involving hnRNP-K could potentially be triggered by a differ-
ent surface receptor. Alternatively, hnRNPK may simply recruit
TCR-activated Lck and, subsequently, assemble a signaling com-
plex, similar as suggested previously (Bomsztyk et al., 2004). To
test this possibility, endogenous hnRNP-K was immunoprecipi-
tated from Jurkat cells that had been stimulated/not stimulated
with anti-CD3/anti-CD28 for 30 min. The immunoprecipitates
were blotted for antiphospho-tyrosine and Lck. As demonstrated
in Figure 3D, in activated—but not in resting—T cells, hnRNP-K
coimmunoprecipitated a number of tyrosine phosphorylated pro-
teins (upper panel), which included Lck (middle panel). In addition,
hnRNP-K itself seemed to be tyrosine phosphorylated as a sub-
fraction of the protein shifted in mobility (see arrow in lower panel).
Taken together, this suggested that hnRNP-K became tyrosine
phosphorylated by TCR-activated Lck early after T cell activation
and, subsequently, recruited the kinase to form a signaling
complex. This result further implied that hnRNP-K did not directly
activate Lck but potentially stabilized the active kinase throughCell Hocrossphosphorylation events within NAKC (see Figure 7 and
Discussion).
Residues 59 and 42 of Lck are the major serine phosphorylation
sites after PMA treatment or TCR stimulation. The phosphory-
lated serines apparently do not modulate the kinase activity of
Lck but change its substrate specificity (Joung et al., 1995;
Park et al., 1995). Phosphorylation is mediated by Erk1/2 (S59)
and PKC (S42), and only phosphorylation of S59 by Erk1/2
causes a visible shift in Lck mobility (Schroder et al., 2000; Watts
et al., 1993; Winkler et al., 1993). In order to identify the Lck phos-
phorylating serine kinase, we tested both Lck serine point mu-
tants (LckS59A and LckS42A) for their shift pattern upon NAKC
formation. The mutants were cotransfected with hnRNP-K and
Nef into 293T cells, and their cytoplasmic lysates were blotted
for Lck. As demonstrated in Figure 4A, the S59A, but not the
S42A mutant, failed to shift in mobility upon NAKC formation.
This implied that NAKC-associated Lck was phosphorylated by
Erk1/2.
Next, we asked whether NAKC formation caused the activa-
tion of Erk1/2, which then phosphorylated Lck. Lysates of 293T
cells, which had been transfected with Lck, Nef, and hnRNP-K,
or KDPxxP instead of hnRNP-K, were blotted for activated
endogenous Erk1/2 using a phospho-specific antibody. As dem-
onstrated in Figure 4B (upper panel), cotransfection of wild-type
hnRNPK, Lck, and Nef was sufficient to activate Erk1/2. Con-
versely, deletion of the proline-rich region in hnRNP-K abolished
this effect (Figure 4C, upper panel) as well as serine phosphory-
lation of Lck (Figure 4C, lower panel). Control western blots
revealed a mobility shift of a small amount of hnRNP-K, probably
representing the Lck-phosphorylated subfraction, as revealed
by an antiphospho-tyrosine western blot (Figure 4B). In sum-
mary, we had demonstrated that NAKC activated Erk1/2.
Since activation of Erk1/2 is an important downstream event
that links membrane signaling with transcription, we aimed to
analyze its activation and interaction with Lck/NAKC in greaterst & Microbe 4, 398–408, October 16, 2008 ª2008 Elsevier Inc. 401
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HIV Nef Activates Lck and Erk1/2 via hnRNP-KFigure 3. The Proline-Rich Domain of hnRNP-K Recruits Activated Lck
(A) Deletion of the proline-rich region in hnRNP-K abolishes association with Lck. hnRNP-K or a deletion mutant (KDPxxP) were cotransfected with Lck. At 24 hr
later, hnRNP-K and KDPxxP were immunoprecipitated and blotted for Lck.
(B) Deletion of the proline-rich region in hnRNP-K does not abolish tyrosine phosphorylation by Lck. Same procedure as in (A); however, the immunoprecipitated
K proteins were blotted with an antiphosphotyrosine antibody (4G10) while lysates of the transfected cells were blotted for hnRNP-K/KDPxxP (lower panel).
(C) Deletion of the proline-rich domain in hnRNP-K inhibits the mobility shift of Lck. Lck was cotransfected with Nef and hnRNP-K or KDPxxP into 293T cells,
immunoprecipitated, and subjected to an in vitro kinase assay (IVKA, upper panel). In addition, the NC filter was probed with an antiphosphotyrosine antibody
(lower panel). Note that, while tyrosine phosphorylation visualizes the mobility shift of Lck, the shift is actually caused by serine phosphorylation.
(D) hnRNP-K is tyrosine phosphorylated and associates with Lck following TCR activation. Jurkat cells were activated/nonactivated by anti-CD3/CD28 for 30 min
before endogenous hnRNP-K was immunoprecipitated and blotted with an antiphosphotyrosine antibody (upper panel). The same NC filter was stripped and
reprobed with an anti-Lck antibody (middle panel). In parallel, lysates of the stimulated cells were blotted for hnRNP-K (lower panel).detail. Unexpectedly, we were unable to coimmunoprecipitate
Erk1/2 with hnRNP-K or any other NAKC factor (data not shown).
Therefore, we wondered where Nef-activated Erk1/2 was local-
ized. Nef, hnRNP-K, and Lck were cotransfected into 293T cells,
which were subsequently stained for activated Erk1/2 and
Nef and analyzed by confocal microscopy. As demonstrated
in Figure 4D (upper panels), activated Erk1/2 was found mainly
in the cytoplasm and colocalized with Nef at the plasma mem-
brane (in 64% of Nef-transfected cells, p < 0.0015), suggesting
that the kinase was recruited to the NAKC complex despite neg-
ative coimmunoprecipitation results. Without cotransfection of
hnRNP-K and Lck, Nef did not activate or colocalize with Erk1/2
(middle and lower panels), implying a recruitment of Erk1/2 to
Nef after NAKC had formed.
Since we could not establish a link between the described
NAKC factors and Erk1/2, we asked whether PI-3 kinase was
involved. We have previously demonstrated that the Nef N termi-
nus recruits PI-3 kinase (Wolf et al., 2001), and the kinase was
found to be involved in Erk1/2 activation (Bondeva et al., 1998;
Duckworth and Cantley, 1997). Performing 293T transfection ex-
periments, we found that overexpression of p85, the regulatory402 Cell Host & Microbe 4, 398–408, October 16, 2008 ª2008 Elseviesubunit of PI-3 kinase, completely blocked NAKC-mediated ac-
tivation of Erk1/2 (Figure 5A, lane 3). Conversely, coexpression of
a transdominant-negative PDK (PH-domain deleted), a down-
stream effector of PI-3 kinase, or a transdominant-negative
Pak kinase (PAK-R) (Wolf et al., 2001), an activator of the MAP
kinase pathway and Nef interactor, or a transdominant-negative
(kinase dead) PKCd had no effect (Figure 5A). Confirming this
finding, we could demonstrate that hnRNP-K precipitated p85
in cotransfection experiments (Figure 5B, lane 5). The associa-
tion did not depend on the proline-rich region since KDPxxP
was still able to bind p85 (lane 6). In summary, these results
suggested that PI-3 kinase was physically and functionally part
of NAKC and involved in Erk1/2 activation.
The activation of Erk1/2 by NAKC was also demonstrated in
Jurkat T cells. For this, NAKC components (Nef, Lck, PKC,
Eed, and K or KDPxxP) were cotransfected in increasing
numbers followed by an analysis of the cellular lysates by
western blot. As demonstrated in Figure S2, all NAKC compo-
nents were required to activate Erk1/2 and, similar as in the
293T transfection experiments, the KDPxxP mutant abolished
this effect. As shown above, a small proportion of hnRNP-Kr Inc.
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HIV Nef Activates Lck and Erk1/2 via hnRNP-KFigure 4. NAKC Activates Erk1/2
(A) Serine 59 of Lck is phosphorylated upon NAKC assembly. Lck and two point mutants (LckS59A and LckS42A) were cotransfected with Nef and hnRNP-K into
293T cells. At 24 hr later, lysates of the transfected cells were blotted for Lck.
(B) Nef, hnRNP-K, and Lck are sufficient to activate Erk1/2. Nef, hnRNP-K, and Lck were cotransfected into 293T cells. After 24 hr, cell lysates were blotted
for activated Erk1/2 (phospho-Erk1/2) and controls. Note that a fraction of hnRNP-K shifted in mobility (see arrows), which seemed to correlate with tyrosine
phosphorylation.
(C) Deletion of the proline-rich domain in hnRNP-K abolishes Erk1/2 activation. Nef, Lck, and hnRNP-K or KDPxxP were cotransfected into 293T cells as
described above. Cell lysates were blotted for phospho-Erk1/2, Lck, and controls.
(D) Nef and phospho-Erk1/2 colocalize at the plasma membrane. Nef, Lck, and hnRNP-K or controls were cotransfected into 293T cells as indicated.
Subsequently, Nef was costained with phospho-Erk1/2 or Erk1/2 and analyzed by confocal microscopy.shifted in mobility, possibly representing a tyrosine phosphory-
lated subfraction.
Next, we asked whether NAKC-mediated activation of Erk1/2
would correlate with the activation of Tat-dependent HIV tran-
scription as shown for CD8-Eed in Figure 1. First, we determined
the relative importance of individual NAKC factors. We trans-
fected Lck and various combinations of NAKC components
into J.CaM.1 cells along with suboptimal levels of Tat and anCell HoHIV-LTR-Luc reporter as described above. In summary, trans-
fection of all five NAKC components gave the highest fold
increase of transactivation, which was up to 60-fold over
background (Figure 6A, lane 12). Conversely, the combination
of only two to four factors had a significantly reduced effect
(lanes 6–11). Thus, all NAKC components were essential for
optimal stimulation of transcription. However, in the absence
of only one kinase (Lck or PKC), transactivation was significantlyFigure 5. PI-3 Kinase Is Functionally and Physically Involved in NAKC
(A) Overexpression of PI-3 p85 inhibits NAKC-mediated Erk1/2 activation. Nef, Lck, and hnRNP-K were cotransfected into 293T cells along with transdominant-
negative mutants of PDK (PDKDPH), PAK (PAK-R), and PKCd (PKCdDkinase). At 24 hr later, cell lysates were blotted for phospho-Erk1/2 and Erk.
(B) hnRNP-K associates with PI-3 p85. hnRNP-K or KDPxxP and p85 were cotransfected into 293T cells in different combinations as indicated. At 24 hr later, the
K proteins were immunoprecipitated and blotted for p85.st & Microbe 4, 398–408, October 16, 2008 ª2008 Elsevier Inc. 403
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HIV Nef Activates Lck and Erk1/2 via hnRNP-KFigure 6. NAKC Activates Tat-Dependent HIV Transcription by Transcriptional Derepression
(A) Lck was cotransfected with NAKC factors in various combinations into J.Cam.1 cells along with suboptimal amounts of Tat and an HIV-LTR luciferase reporter
as indicated. At 16 hr later, cells were analyzed for luciferase activity indicated in fold activation above background (Lck and mock). Control western blots in 293T
cells showed that NAKC did not increase Tat expression in the transcription assays (insert). Error bars show means ± SD from three independent experiments.
The p values in the graph were calculated on the basis of the mean values of the indicated bars.
(B) The NF-kB-motif in the HIV promoter is required for transcriptional effects of NAKC. Different HIV-LTR luciferase reporter constructs were cotransfected with
NAKC (Nef, Lck, PKC, Eed, hnRNP-K) and Tat and analyzed for luciferase activity. HIV-LTR, wild-type HIV-promoter; sh-LTR (nts 345–531), promoter sequence
upstream of the NF-kB element deleted; sh-LTRDNF-kB, same as sh-LTR plus mutation of the NF-kB motif. Error bars show means ± SD from three independent
experiments. The p value in the graph was calculated on the basis of the mean values of the indicated bars. p < 0.0017.
(C) siRNA knockdown of hnRNP-K activates Erk1/2. Jurkat cells were transfected three times with siRNA probes specific for hnRNP-K and analyzed for hnRNP-K
expression and phospho-Erk1/2 activation before and after stimulation with anti-CD3/CD28.
(D) siRNA knockdown increases rescue of latent HIV by T cell activation stimuli. J.Lat Jurkat cells were transfected three times with hnRNP-K-specific siRNA as in
(C), resulting in a roughly 50% reduction of hnRNP-K expression (data not shown). Then, cells were stimulated with anti-CD3/CD28, PMA, or TNF and analyzed for
GFP expression by FACS after 12 hr. Cell culture aliquots were treated with the Erk1/2 inhibitor U0126 (Promega) as indicated. Error bars show means ± SD from
three independent experiments. The p values in the graph were calculated on the basis of the mean values of the indicated bars.
Error bars in (A), (B), and (D) were calculated on the basis of three experiments.reduced. Likewise, the omission of hnRNP-K had a greatly
reduced effect (lane 14). Notably, the increase in transcription
was not due to an increase of Tat expression through NAKC,
as shown by an anti-Tat western blot after NAKC transfection
into 293T cells (Figure 6A, insert). Together, these results sug-
gested that (1) NAKC was a coherent signaling module that stim-
ulated Tat transactivation, and (2) the activities of both kinases,
Lck and PKC, as well as their docking platform hnRNP-K were
essential for this effect.
In order to map the NAKC transcriptional effect on the HIV
promoter, we repeated the transcription assay using a minimal
promoter lacking sequences upstream of the NF-kB site (sh-HIV-
LTR, nts 345–531). In addition, we used the same construct with
a mutated NF-kB site (sh-HIV-LTRDNFkB). First, we found that
NAKC still increased Tat transactivation using the minimal pro-
moter, albeit not as efficiently as with the wild-type promoter404 Cell Host & Microbe 4, 398–408, October 16, 2008 ª2008 Elsev(Figure 6B, p < 0.0017). Mutation of the NF-kB site, however,
completely abolished transactivation, implying that NAKC
directly targeted NF-kB. However, despite numerous different
experimental approaches, we were never able to demonstrate
an effect of Nef or NAKC on NF-kB (V.W. et al., unpublished
data and data not shown). Therefore, we assumed that NAKC
targeted (a) so far unknown inhibitory factor(s) that occupied
the NF-kB recognition motif and inhibited Tat transactivation
(see Discussion).
Erk1/2 is an important regulator of transcription factors and
chromatin-modifying proteins and, thus, the likely mediator of
NAKC effects on Tat transactivation. Therefore, we hypothesized
that depletion of hnRNP-K by siRNA would reduce TCR-
mediated activation of Erk1/2 and HIV transcription. First, we in-
vestigated TCR-mediated activation of Erk1/2 after hnRNP-K de-
pletion. Despite different approaches and multiple transfections,ier Inc.
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HIV Nef Activates Lck and Erk1/2 via hnRNP-KFigure 7. Model of NAKC Formation and Downstream Events
(A) NAKC formation and transcriptional derepression. (1) Eed and hnRNP-K are shuttle proteins. In resting cells, they exert a repressive effect on HIV transcription
and Erk1/2. Upon Nef expression, their shuttle equilibrium shifts to the cytoplasm. (2) Targeted to the membrane, hnRNP-K recruits active Lck out of an equi-
librium between active and nonactive molecules. (3) NAKC formation leads to the activation of Erk1/2, phosphorylation of hnRNP-K (Habelhah et al., 2001),
and potential inhibitors affecting their shuttling equilibrium.
(B) NAKC formation and Erk1/2 activation. (1) Activated Lck phosphorylates hnRNP-K (Figure 3 and Ostrowski et al., 2000). (2) Upon Lck binding, additional
tyrosines are phosphorylated, creating SH2 docking sites (Bomsztyk et al., 2004; Ostrowski et al., 2000). (3) Both events (1) and (2) lead to the recruitment of
PKCd (Schullery et al., 1999) and PI-3 kinase (Figure 5) and, thus, to NAKC formation. This induces the crossphosphorylation of Lck by PKC (Baur et al.,
1997) and potentially the tyrosine phosphorylation of p85 (von Willebrand et al., 1994). (4) After NAKC has formed, Erk1/2 is recruited, potentially in a PI-3
kinase-dependent manner (Figure 5). The next phosphorylation steps leading to Erk1/2 activation are not clear; however, PKC and PI-3 kinase are likely involved
as documented in the literature. (5) Activated Erk1/2 finally phosphorylates Lck and hnRNP-K.we could not deplete more than roughly 50% of endogenous
hnRNP-K in Jurkat cells using commercial probes (Figure 6C, up-
per panel). Nevertheless, we tested these cells for Erk1/2 activa-
tion. To our surprise, reduction of hnRNP-K greatly induced Erk1/2
activity, whereas stimulation through the T cell receptor did not
show a difference (Figure 6C, middle panel). This suggested
that, in resting T cells, hnRNP-K inhibited Erk1/2 activity, whereas
this inhibitory function was reversed upon NAKC assembly.
To solidify this assumption, we asked whether a depletion/
reduction of hnRNP-K by siRNA had a stimulating effect on
HIV transcription using a previously described Jurkat latency
model of HIV (J.Lat) (Jordan et al., 2003). These cells contain
a single full-length HIV provirus in which the Nef gene is replaced
by GFP. In our hands, treatment of these cells with CD3/CD28,
PMA, or TNF for 12 hr only slightly increased the number of GFP-
expressing cells (from 2% to 4%–5%) (Figure 6D, no. 1 bars).
Conversely, simultaneous reduction of hnRNP-K by siRNA
(50%) roughly doubled (PBS, CD3/CD28, TNF) or tripledCell Hos(PMA) the number of GFP-expressing cells (Figure 6D, no. 3
bars), whereas addition of the Erk1/2 inhibitor (U0126, Promega)
reversed this effect (no. 4 bars). Taken together, these results
were in agreement with our previous experiments (Figure 6B)
(Witte et al., 2004), suggesting that the NAKC/Erk1/2 effect on
Tat transactivation was caused by derepression and not by
direct stimulation of the HIV promoter. Potentially, this enabled
transcription factors like NF-kB and Tat to act at lower concen-
trations (Figure 7A).
DISCUSSION
The present study is a continuation of our previous work
intended to determine the signaling mechanism by which Nef
supports HIV transcription. With the current report, we have
reached three conclusions. First, hnRNP-K is a docking platform
for several key kinases in T cells. Second, the activation of Erk1/2
is a main consequence of this hnRNP-K-nucleated complex.t & Microbe 4, 398–408, October 16, 2008 ª2008 Elsevier Inc. 405
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HIV Nef Activates Lck and Erk1/2 via hnRNP-KThird, NAKC/Erk1/2-mediated signaling leads to the derepres-
sion of the HIV promoter, enabling suboptimal amounts of Tat
and transcription factors like NF-kB to initiate transcription.
Supporting our model, we have now identified the factor that
regulates the accessibility of the NF-kB element and is removed
by NAKC signaling (V.W. et al., unpublished data). We assume
that, under conditions with limited availability of positive tran-
scription factors, promoter derepression is essential for HIV to
initiate replication. These conditions likely exist in nonactivated
primary T cells and at the beginning of HIV transcription, which
may even start before the virus is integrated (Wu and Marsh,
2001). Moreover, viral promoters, integrated or not, are rapidly
occupied by repressive factors as implied by ChIP assays with
transiently transfected HIV promoters, demonstrating the pres-
ence of Eed (Witte et al., 2004). Experiments using fast replicat-
ing tumor cells may not adequately reflect this situation, although
we demonstrate here an up to 60-fold increase of Tat transacti-
vation in the presence of NAKC. Taken together, promoter dere-
pression by Nef may be a crucial step to initiate transcription in
the repressive nuclear environment of a primary T cell.
hnRNP-K is a predominant nuclear protein that associates
with RNA and DNA like its direct interactor, the polycomb protein
Eed. In this function, both proteins may cooperatively act as
inhibitors of transcription—Eed by recruiting HDAC proteins
(van der Vlag and Otte, 1999) and hnRNP-K by binding repres-
sive factors like Zik1 or Eed (Denisenko and Bomsztyk, 1997;
Denisenko et al., 1996) and/or by inhibiting Erk1/2 activity as
implied by the data shown here (Figure 7A). Possibly upon trans-
location to the plasma membrane and posttranslational modifi-
cation, both proteins exchange this inhibitory for an activating
role in transcription by serving as a docking platform for acti-
vated cytoplasmic kinases. This functional conversion may
be induced upon NAKC formation or other activating stimuli.
In the course of this transformation, Erk1/2 is activated and
may induce transcriptional derepression by activating histone-
modifying kinases and phosphorylating hnRNP-K, which leads
to its cytoplasmic translocation (Habelhah et al., 2001). A com-
parable mechanism has been described for the transcriptional
repressor Yan, which, upon Erk1/2 phosphorylation, is shuttled
to the cytoplasm while, simultaneously, Erk1/2 phosphorylates
the transcription factor Ets-AP1, which replaces Yan and en-
hances gene transcription (O’Neill et al., 1994). For the results
presented here, we would also assume that the HIV promoter
and NF-kB motif are occupied by a transcriptional repressor,
which needs to be replaced before transcription factors are
able to bind. Aside from its repressive function, the role of Eed
in this scenario is unclear; however, it has been established
that hnRNP-K is methylated on two arginines, which modulates
its function (Ostareck-Lederer et al., 2006). The latter is poten-
tially induced by Eed and associated Suz12/Ezh2 proteins.
Our results imply that NAKC directly activated Lck by an alter-
native mechanism: (1) NAKC-dependent activation of the kinase
in a non-T cell environment, (2) the involvement of multiple T cell
kinases, (3) the presence of a signaling docking platform (hnRNP-
K, Eed), and (4) the strong autophosphorylation activity of Lck
after coprecipitation through Nef argue for this assumption.
However, we were unable to demonstrate a plausible mecha-
nism—for example, a classical PxxP-SH3 interaction (Figure 3)—
that would displace the Lck SH3 domain from its intramolecular406 Cell Host & Microbe 4, 398–408, October 16, 2008 ª2008 Elsevlock as demonstrated for Nef and HCK (Moarefi et al., 1997).
Rather, hnRNP-K appeared to be an immediate downstream ef-
fector of the T cell receptor that associated with TCR-activated
Lck. In view of our results, we suggest that membrane-targeted
hnRNP-K recruits activated Lck molecules out of a CD45/Csk-
controlled equilibrium with inactive Lck (Palacios and Weiss,
2004) (Figure 7A). We would further speculate that assembly of
the kinases at the hnRNP-K docking platform stabilizes active
Lck molecules by crossphosphorylation. This would still qualify
hnRNP-K as an activator of Lck similar, as demonstrated for
c-Src (see Figure 7B). In summary, our findings do not provide
enough evidence to propose an alternative mechanism of direct
Lck activation through hnRNP-K; however, such a mechanism
cannot be ruled out completely.
Although Nef is clearly a stimulating accessory protein of HIV,
it has been very difficult to demonstrate its positive effects on
signaling molecules/pathways and/or transcription. Results
from different labs often have been contradictory, and positive
effects of Nef in general require T cell costimulation (Schrager
and Marsh, 1999). For example, an increased Erk1/2 activation
by Nef was demonstrated upon costimulation with anti-CD3
(Schrager et al., 2002). Our study presented here may provide
an explanation for this conundrum. The formation of a multimeric
signaling complex requires all factors to be available in a bal-
anced amount. Overexpression of one factor may lead to the
precipitation of a cofactor in lower quantities and ultimately
causes a squelching effect. We envision such a mechanism for
some of the results in Figure 2 when not all NAKC factors were
cotransfected. We would assume that the Nef signaling complex
forms early in the replication cycle when Nef levels are below
those of the interacting partners. Such conditions exist at the
very beginning of viral replication. After several rounds of tran-
scription, Tat is the more important factor for viral replication,
and Nef is dispensable and/or required for additional functions
like CD4 downmodulation. This model would explain why the
Nef effect on transcription is entirely Tat dependent but at the
same time absolutely essential in a short time frame of the viral
life cycle.
EXPERIMENTAL PROCEDURES
Cell Lines, Antibodies, and Recombinant Proteins
Jurkat cells and their derivatives, J.CaM1, J.Lat, and the inducibe Nef-mER
cell line, were cultured in RPMI 1640, 10% FCS; 293T cells in DMEM, 10%
FCS. Sf9 insect cells were maintained in Sf-900 II SFM media. The Nef-
inducible cell line was established using Jurkat ‘‘Tet-On’’ cells as described
previously (Witte et al., 2004), expressing a Nef-(tamoxifen-sensitive) estrogen
receptor fusion protein (mER) controlled by a Tetracycline-responsive ele-
ment. Addition of doxycycline overnight caused expression of an inactive
Nef protein, which was rendered active by addition of tamoxifen.
The sheep a-Nef serum was a gift from M. Harris and used at a dilution of
1:5000. The polyclonal a-Eed serum was raised in rabbits as described previ-
ously (Witte et al., 2004). The antibodies a-myc (clone 9E11), a-AU-1, and a-HA
were purchased from Covance; the monoclonal antibodies a-hnRNP-K (clone
D-6), a-Lck (clone 3A5), and a-PKCd (clone C17), from Santa Cruz; a-Erk and
a-phospho-Erk (Thr 202/204), from Cell Signaling; the a-phospho-tyrosine
antibody (4G10), from Upstate; the a-CD3 (Clone HIT 3a) and a-CD28 (clone
CD28.2 L293) for stimulation, from Becton Dickinson. The secondary
a-mouse- and a-rabbit-HRP conjugated antibodies were from Promega; the
a-sheep-HRP, from Sigma. The AlexaFluor488-conjugated goat a-sheep,
AlexaFluor568/647 goat a-mouse, and AlexaFluor568 goat a-rabbit were
from Molecular Probes.ier Inc.
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Geyer, Dortmund, Germany. Recombinant GST-Eed was obtained and puri-
fied after bacterial expression. Recombinant proteins for hnRNP-K, Lck, and
PKCd were generated using the Baculovirus Expression System from Invitro-
gen according to the manufacturer’s instructions.
Plasmids
The CD8-Nef fusion proteins (SF2 full-length and truncated forms) as well as
Nef-AU1 were generated as described previously (Baur et al., 1997). Human
isoforms of PKCd and PKCq, including PKCq-K/R, were obtained from Gott-
fried Baier, Innsbruck, Austria. A HA tag was added as described previously
(Wolf et al., 2008). The expression plasmid for p85 was kindly provided by A.
Klippel. Lck and Hck expression plasmids were obtained from Arthur Weiss,
San Francisco and Kalle Saksela, Helsinki. The S59A and S42A as well as
K273R (kinase dead) mutations in Lck were introduced by site-directed muta-
genesis. The expression plasmid for hnRNP-K was a kind gift from Karol
Bomsztyk. The deletion of the PXXP region (aa 289–315) was introduced by
overlapping PCR. The transdominant-negative PAK (PAK-R; aa1-225) expres-
sion plasmid was obtained from Matija Peterlin, San Francisco. PDKDPH
(deleted PH domain) was obtained from Alex Toker, Philadelphia. Tat, HIV-
LTR-Luc (pGL2basic), sh-HIV-LTR-Luc (pEV284), and sh-HIV-LTR-LucDNF-
kB (pEV285) were obtained from Melanie Ott, San Francisco.
Transfections into T and 293T Cells
Transient transfections into 293T cells were performed as described previ-
ously (Wolf et al., 2001). For transient transfection of Jurkat cells, 103 106 cells
were electroporated using up to 50 mg of DNA. J.CaM.1 cells for Luciferase
reporter assays were transfected using DMRIE-C according to the manufac-
turer’s instructions. For delivery of the siRNA (purchased from Dharmacon),
cells were electroporated using a square-wave protocol. To obtain an 50%
knockdown of hnRNP-K, the electoporation was repeated three times within
3 days.
Protein Assays
Immunoprecipitations, western blots, and in vitro kinase assays were per-
formed as described previously (Baur et al., 1997; Witte et al., 2004; Wolf
et al., 2001). For the luciferase reporter assays, J.CaM.1 cells were harvested
16 hr after transfection, and luciferase activity was measured using the Dual-
Luciferase Reporter Assay System from Promega according to the manufac-
turer’s instructions.
Immunofluorescence and Confocal Microscopy
293T cells were grown and transfected on glass coverslips before staining.
T cells were plated on Poly-L-Lysine-coated (Becton Dickinson) glass cover-
slips for 10–20 min at 37C to adhere before staining. Subsequently, cells
were fixed with 3% paraformaldehyde, permeabilized using 1% Triton-X,
blocked with 1% BSA, and stained with the corresponding antibodies. Slides
were analyzed on a Zeiss confocal LSM 510 microscope (Carl Zeiss, Thorn-
wood, NY) using the corresponding software (Zeiss LSM Image Browser).
Confocal scanning settings were not changed nor was the staining intensity
enhanced by subsequent picture processing for each individual antibody.
SUPPLEMENTAL DATA
The Supplemental Data include two figures and can be found with this article on-
line at http://www.cellhostandmicrobe.com/cgi/content/full/4/4/398/DC1/.
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